GNMK News and Press, GenMark Diagnostics Inc. From 07/07/20

GenMark Diagnostics (NASDAQ: GNMK ) expects Q2 sales to be ~$40.1M, up 118% Y/Y, as COVID-19 impacted second quarter placements and revenue. More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

CARLSBAD, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary financial and operational results for the quarter ended June 30, 2020. Second Quarter ...

CARLSBAD, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that its ePlex® Respiratory Pathogen 2 (RP2) Panel is now available for U.S. commercial distribution a...

CARLSBAD, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, has been selected by Vidant Health as its primary provider of rapid diagnostic testing. Vidant is deploying GenMark&#...

Rebellion shows too much respect for authority .”― Marty Rubin Today we take an in-depth look at a small-cap medical diagnostic firm that appears to be one of the few companies benefiting from the COVID-19 pandemic. A full analysis is provided in the paragraphs below. C...

In what can only be described as a rough year for public markets, a select group of stocks has managed to buck the trend. Investors seek to uncover these hidden gems to help their portfolios thrive through turbulent times. Healthcare, and biotechnology in particular, has been a bright spot, outp...

CARLSBAD, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing multiplex molecular diagnostic solutions designed to enhance patien...

Gainers:  Tetraphase Pharmaceuticals (NASDAQ: TTPH ) +90% . More news on: Tetraphase Pharmaceuticals, Inc., ION Geophysical Corporation, Twilio Inc., Stocks on the move, , Read more ...

Are These The Best Penny Stocks Under $4 To Buy? A wise person once told me just because something’s inexpensive, doesn’t mean it’s a good buy. Where many penny stocks tend to run for a day or two, others can actually spread their wings and fly for months. As we’v...

ION Geophysical (NYSE: IO ) +87%  on Q1 results . More news on: ION Geophysical Corporation, Tetraphase Pharmaceuticals, Inc., Fastly, Inc., Stocks on the move, , Read more ...